CN115960085A - Preparation method of fluoro-oxindole heterocyclic compound - Google Patents
Preparation method of fluoro-oxindole heterocyclic compound Download PDFInfo
- Publication number
- CN115960085A CN115960085A CN202211335843.8A CN202211335843A CN115960085A CN 115960085 A CN115960085 A CN 115960085A CN 202211335843 A CN202211335843 A CN 202211335843A CN 115960085 A CN115960085 A CN 115960085A
- Authority
- CN
- China
- Prior art keywords
- preparation
- reaction
- structural formula
- heterocyclic compound
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 fluoro-oxindole heterocyclic compound Chemical class 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 60
- 229910052684 Cerium Inorganic materials 0.000 claims abstract description 11
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 15
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 12
- 229910052794 bromium Inorganic materials 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000003208 petroleum Substances 0.000 claims description 12
- 125000001246 bromo group Chemical group Br* 0.000 claims description 11
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 11
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 11
- 125000001041 indolyl group Chemical group 0.000 claims description 7
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 7
- 229930185107 quinolinone Natural products 0.000 claims description 7
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 238000000967 suction filtration Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000003682 fluorination reaction Methods 0.000 abstract description 2
- 125000000524 functional group Chemical group 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 125000001424 substituent group Chemical group 0.000 abstract description 2
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 239000010970 precious metal Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 47
- 239000000243 solution Substances 0.000 description 26
- 239000000047 product Substances 0.000 description 13
- 239000012074 organic phase Substances 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- BLRHMMGNCXNXJL-UHFFFAOYSA-N 1-methylindole Chemical compound C1=CC=C2N(C)C=CC2=C1 BLRHMMGNCXNXJL-UHFFFAOYSA-N 0.000 description 4
- CHPVQLYVDDOWNT-UHFFFAOYSA-N 1-methylquinoxalin-2-one Chemical compound C1=CC=C2N=CC(=O)N(C)C2=C1 CHPVQLYVDDOWNT-UHFFFAOYSA-N 0.000 description 4
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- HIOJKWCIURECFH-UHFFFAOYSA-N 1-(cyclohexylmethyl)indole Chemical compound C1=CC2=CC=CC=C2N1CC1CCCCC1 HIOJKWCIURECFH-UHFFFAOYSA-N 0.000 description 3
- DGKOFMLBEWYZLR-UHFFFAOYSA-N 1-prop-2-ynylquinoxalin-2-one Chemical compound C1=CC=C2N(CC#C)C(=O)C=NC2=C1 DGKOFMLBEWYZLR-UHFFFAOYSA-N 0.000 description 3
- SBOITLSQLQGSLO-UHFFFAOYSA-N 5-bromo-1-methylindole Chemical compound BrC1=CC=C2N(C)C=CC2=C1 SBOITLSQLQGSLO-UHFFFAOYSA-N 0.000 description 3
- XZCNHDAUOLXBPV-UHFFFAOYSA-N 6-bromo-1-methylquinolin-2-one Chemical compound C1=C(Br)C=C2C=CC(=O)N(C)C2=C1 XZCNHDAUOLXBPV-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- XEEANGGQJOWRTG-UHFFFAOYSA-N 1h-indol-2-ylmethanol Chemical compound C1=CC=C2NC(CO)=CC2=C1 XEEANGGQJOWRTG-UHFFFAOYSA-N 0.000 description 1
- GTQFGAJYMBBUSO-UHFFFAOYSA-N 2-diazoacetamide Chemical compound NC(=O)C=[N+]=[N-] GTQFGAJYMBBUSO-UHFFFAOYSA-N 0.000 description 1
- OBIVZIJHRGYOPJ-UHFFFAOYSA-N 2h-oxireno[2,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1O2 OBIVZIJHRGYOPJ-UHFFFAOYSA-N 0.000 description 1
- MXIRBQGJHHAAIX-UHFFFAOYSA-N 3-fluoro-1,3-dihydroindol-2-one Chemical class C1=CC=C2C(F)C(=O)NC2=C1 MXIRBQGJHHAAIX-UHFFFAOYSA-N 0.000 description 1
- VMITYLJHUKSVIC-UHFFFAOYSA-N 3-fluoro-1h-indole Chemical class C1=CC=C2C(F)=CNC2=C1 VMITYLJHUKSVIC-UHFFFAOYSA-N 0.000 description 1
- VXWVFZFZYXOBTA-UHFFFAOYSA-N 5-bromo-1h-indole Chemical compound BrC1=CC=C2NC=CC2=C1 VXWVFZFZYXOBTA-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical compound [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 description 1
- 230000000320 anti-stroke effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- UUWSLBWDFJMSFP-UHFFFAOYSA-N bromomethylcyclohexane Chemical compound BrCC1CCCCC1 UUWSLBWDFJMSFP-UHFFFAOYSA-N 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical compound NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000005623 oxindoles Chemical class 0.000 description 1
- 239000002379 progesterone receptor modulator Substances 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Indole Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于化工合成技术领域,具体地说是涉及一种氟代氧化吲哚类杂环化合物的制备方法。The invention belongs to the technical field of chemical synthesis, and in particular relates to a preparation method of fluorinated oxindole heterocyclic compounds.
背景技术Background technique
氧化吲哚类杂环化合物广泛存在于天然产物以及重要的药物分子结构当中,其独特生物学性质在药化领域颇受关注,已经被广泛应用于疾病的治疗,例如抗神经障碍、抗中风以及孕酮受体调节剂等药物。Oxindole heterocyclic compounds widely exist in natural products and important drug molecular structures. Their unique biological properties have attracted much attention in the field of medicinal chemistry and have been widely used in the treatment of diseases, such as anti-neurological disorders, anti-stroke and Drugs such as progesterone receptor modulators.
传统制备3-氟氧化吲哚类衍生物方法主要可以分为两种,一种是对吲哚或者氧化吲哚类衍生物分别进行氟氧化或者亲核氟化,该方法需要较难制得的底物例如2-羟甲基吲哚,螺环环氧吲哚作为底物,以危险性较大的氟化试剂例如氢氟酸胺盐作为氟源,甚至额外添加氧化剂以及碱来促进反应进行,反应条件较为苛刻且步骤复杂;另一种常用的方法以难以制得的丙二酸酰胺或重氮乙酰胺作为环合底物,并加入昂贵的有机金属配合物以及其他添加剂来促进环合反应,因此增加了制备成本以及环境负担,不适合产业化。以上传统的制备方法因其较高的制备成本,繁琐的合成步骤,较低的安全性以及较多的废弃物而显著降低了其实用性,因此必须开发一种高效,环保且经济的氟代氧化吲哚类杂环化合物,尤其是3-氟氧化吲哚类衍生物的制备方法来更好地适用于实际应用领域。The traditional methods for preparing 3-fluoroindole derivatives can be mainly divided into two types. One is to perform fluorine oxidation or nucleophilic fluorination on indole or oxindole derivatives respectively. This method requires relatively difficult to obtain Substrates such as 2-hydroxymethylindole and spirocyclic epoxyindole are used as substrates, and dangerous fluorinated reagents such as ammonium hydrofluoride are used as fluorine sources, and even additional oxidants and bases are added to promote the reaction , the reaction conditions are relatively harsh and the steps are complicated; another commonly used method uses malonamide or diazoacetamide which is difficult to obtain as a cyclization substrate, and adds expensive organometallic complexes and other additives to promote cyclization reaction, thus increasing the preparation cost and environmental burden, it is not suitable for industrialization. The above traditional preparation methods have significantly reduced their practicability due to their higher preparation costs, cumbersome synthesis steps, lower safety and more waste. Therefore, it is necessary to develop an efficient, environmentally friendly and economical fluorinated The preparation method of oxindole heterocyclic compounds, especially 3-fluorooxindole derivatives, is better applicable to the field of practical application.
发明内容Contents of the invention
为了克服现有技术存在的不足,本发明提供了一种操作简便、效率较高的氟代氧化吲哚类杂环化合物(3-(3-氟-2-氧代吲哚-3-基)-喹啉酮类衍生物)的制备方法。In order to overcome the deficiencies in the prior art, the present invention provides a kind of fluorooxindole heterocyclic compound (3-(3-fluoro-2-oxoindol-3-yl) with simple and convenient operation and high efficiency - the preparation method of quinolinone derivatives).
本发明采用的技术方案为:The technical scheme adopted in the present invention is:
一种氟代氧化吲哚类杂环化合物的制备方法,所述氟代氧化吲哚类杂环化合物的结构式如(I)所示:A preparation method of fluoroindole heterocyclic compound, the structural formula of the fluoroindole heterocyclic compound is as shown in (I):
其中,R1为H、甲基、环己基甲基、炔丙基中的任意一种;R2选自下述基团中的任意一种:H、吲哚5位取代的溴、氰基以及吲哚6位取代的酯基;R3选自下述基团中的任意一种:H、甲基、苄基;R4为H、喹啉酮6位取代的氯、溴的任意一种;Wherein, R 1 is any one of H, methyl, cyclohexylmethyl, propargyl; R 2 is selected from any one of the following groups: H, bromine substituted at the 5-position of indole, cyano And an ester group substituted at the 6-position of indole; R3 is selected from any one of the following groups: H, methyl, benzyl; R4 is any one of chlorine and bromine substituted at the 6-position of H, quinolinone kind;
所述氟代氧化吲哚类杂环化合物的制备方法包括下述步骤:The preparation method of the fluorooxindole heterocyclic compound comprises the following steps:
(1)制备结构式如(II)所示化合物;(1) preparation of structural formula such as compounds shown in (II);
(2)制备结构式如(III)所示化合物;(2) preparation of structural formula such as compounds shown in (III);
(3)将结构式如(II)所示化合物、结构式如(III)所示化合物、铈催化剂加入反应容器中,加入溶剂,在室温蓝光照射条件下搅拌反应;随后加入N-氟代双苯磺酰胺,在35~65℃条件下继续搅拌反应;得到结构式如(I)所示产物。(3) Add the compound shown in the structural formula (II), the compound shown in the structural formula (III), and the cerium catalyst into the reaction vessel, add the solvent, and stir the reaction under blue light irradiation at room temperature; then add N-fluorobisbenzenesulfonate Amide, continue stirring and reacting under the condition of 35~65 ℃; Obtain the product shown in structural formula (I).
本发明以光促进铈催化法制备氟代氧化吲哚类杂环化合物(3-(3-氟-2-氧代吲哚-3-基)-喹啉酮类衍生物),其反应过程为:The present invention prepares fluorinated oxindole heterocyclic compound (3-(3-fluoro-2-oxoindol-3-yl)-quinolinone derivatives) with light-promoted cerium catalysis, and the reaction process is as follows: :
作为优选,R1为甲基或环己基甲基;R2为H或吲哚5位取代的溴;R3为甲基;R4为H或喹啉酮6位取代的溴。Preferably, R 1 is methyl or cyclohexylmethyl; R 2 is H or bromine substituted at the 5-position of indole; R 3 is methyl; R 4 is H or bromine substituted at the 6-position of quinolinone.
作为优选,所述铈催化剂为无水氯化铈。Preferably, the cerium catalyst is anhydrous cerium chloride.
作为优选,所述溶剂为乙腈或二氯乙烷。Preferably, the solvent is acetonitrile or dichloroethane.
作为优选,结构式如(II)所示化合物、结构式如(III)所示化合物、N-氟代双苯磺酰胺、铈催化剂的摩尔比为1:1.1:1.5:0.005~0.01。Preferably, the molar ratio of the compound represented by the structural formula (II), the compound represented by the structural formula (III), N-fluorobisbenzenesulfonamide, and the cerium catalyst is 1:1.1:1.5:0.005-0.01.
作为优选,继续搅拌反应的温度为50℃。Preferably, the temperature for continuing to stir the reaction is 50°C.
作为优选,反应完成后,旋干溶剂,以乙醇与水的混合溶液进行重结晶,随后抽滤,洗涤剂选择石油醚/乙酸乙酯的混合溶液洗涤三次,真空干燥得到产品。Preferably, after the reaction is completed, the solvent is spin-dried, recrystallized with a mixed solution of ethanol and water, then suction filtered, washed three times with a mixed solution of petroleum ether/ethyl acetate as a detergent, and vacuum-dried to obtain the product.
本发明所提供的3-(3-氟-2-氧代吲哚-3-基)-喹啉酮类衍生物的制备方法科学合理,采用廉价以及小剂量的铈催化剂,以温和、高效的光促进铈催化法合成一系列3-(3-氟-2-氧代吲哚-3-基)-喹啉酮类衍生物。The preparation method of 3-(3-fluoro-2-oxoindol-3-yl)-quinolinone derivatives provided by the present invention is scientific and reasonable, adopts cheap and low-dose cerium catalyst, and is mild and efficient A series of 3-(3-fluoro-2-oxoindol-3-yl)-quinolinone derivatives were synthesized by light-promoted cerium-catalyzed method.
本发明的有益效果在于:The beneficial effects of the present invention are:
(1)以廉价、高效的氯化铈以及N-氟代双苯磺酰胺作为催化剂以及氟化试剂,与传统合成3-氟氧化吲哚类杂环工艺相比,避免了贵金属的使用,且降低了金属的用量,反应条件更加温和、经济且高效,促进反应体系产业化可能;(1) Using cheap and efficient cerium chloride and N-fluorobisbenzenesulfonamide as catalysts and fluorinating reagents, compared with the traditional synthesis of 3-fluoroindole heterocycles, the use of noble metals is avoided, and The amount of metal used is reduced, the reaction conditions are milder, economical and efficient, and the possibility of industrialization of the reaction system is promoted;
(2)利用可见光促进偶联反应进行,避免了传统偶联反应强酸的使用,更加绿色环保;(2) Using visible light to promote the coupling reaction, avoiding the use of strong acid in the traditional coupling reaction, and being more environmentally friendly;
(3)高效拓展了具有不同取代基的3-(3-氟-2-氧代吲哚-3-基)-喹啉酮类化合物,反应体系具有较好的官能团兼容性且提供较高的收率,目标产物的收率可以高达90%以上。(3) Efficiently expanded 3-(3-fluoro-2-oxoindol-3-yl)-quinolinone compounds with different substituents, the reaction system has better functional group compatibility and provides higher Yield, the yield of the target product can be as high as more than 90%.
附图说明Description of drawings
图1是实施例1制备得到的3-(3-氟-1-环己基甲基-2-氧代吲哚-3-基)-1-甲基喹啉-2(1H)-酮的核磁氢谱图。Fig. 1 is the NMR of 3-(3-fluoro-1-cyclohexylmethyl-2-oxoindol-3-yl)-1-methylquinolin-2(1H)-one prepared in Example 1 Hydrogen Spectrum.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步说明,但本发明所要保护的范围并不限于此。本领域的普通技术人员可以且应当知晓任何基于本发明实质精神的简单变化或者替换均应属于本发明所要求的保护范围。The present invention will be further described below in conjunction with specific examples, but the protection scope of the present invention is not limited thereto. Those skilled in the art can and should know that any simple changes or substitutions based on the essence and spirit of the present invention shall fall within the scope of protection required by the present invention.
实施例1Example 1
N-环己基甲基吲哚的制备(结构式(II)中的R1为环己基甲基,R2为H)Preparation of N-cyclohexylmethylindole (R in structural formula (II) 1 is cyclohexylmethyl, R 2 is H)
在50mL圆底烧瓶中分别加入吲哚(13.2mmol,1.55g),氢氧化钾(46.2mmol,2.60g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加(溴甲基)环己烷(15.84mmol,2.80g)的DMF溶液,滴加完毕后在室温下继续反应3个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,干燥,旋干,以石油醚和乙酸乙酯(80:1)比例为洗脱液过柱纯化,晾干后得到N-环己基甲基吲哚。Add respectively indole (13.2mmol, 1.55g) in 50mL round bottom flask, potassium hydroxide (46.2mmol, 2.60g), 15mL N,N-dimethylformamide (DMF), stir under ice bath, then A DMF solution of (bromomethyl)cyclohexane (15.84 mmol, 2.80 g) was added dropwise to the round bottom flask, and after the addition was completed, the reaction was continued at room temperature for 3 hours, and the reaction was detected by TLC. After the reaction was completed, the reaction solution was washed with saturated ammonium chloride solution, extracted with ethyl acetate, and the organic phase was washed with brine, the organic phase was separated, dried, spin-dried, and extracted with petroleum ether and ethyl acetate (80:1 ) ratio is that the eluent is purified through the column, and N-cyclohexylmethylindole is obtained after drying.
N-甲基喹喔啉酮的制备(结构式(III)中R3为甲基、R4为H)Preparation of N-methylquinoxalinone ( R in structural formula (III) for methyl, R for H)
在100mL圆底烧瓶中分别加入2-羟基喹喔啉酮(12mmol,1.75g),碳酸钾(24mmol,3.31g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加碘甲烷(14.4mmol,2g)的DMF溶液,滴加完毕后在室温下继续反应6个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,旋干得到粗品,粗品再用乙酸乙酯/石油醚(1:4)进行重结晶得到较纯的N-甲基喹喔啉酮。Add respectively 2-hydroxyquinoxalinone (12mmol, 1.75g), potassium carbonate (24mmol, 3.31g), 15mL N,N-dimethylformamide (DMF) in 100mL round bottom flask, stir under ice bath , then dropwise the DMF solution of iodomethane (14.4mmol, 2g) in the round bottom flask, continue to react at room temperature for 6 hours after the dropwise addition, and the reaction is detected by TLC. After the reaction was completed, the reaction solution was washed with saturated ammonium chloride solution, extracted with ethyl acetate, the organic phase was washed with brine, the organic phase was separated, and spin-dried to obtain the crude product, which was then washed with ethyl acetate/petroleum ether (1 : 4) carry out recrystallization to obtain purer N-methylquinoxalinone.
3-(3-氟-1-环己基甲基-2-氧代吲哚-3-基)-1-甲基喹啉-2(1H)-酮的制备(结构式(I)中R1为环己基甲基、R2为H、R3为甲基,R4为H)The preparation of 3-(3-fluoro-1-cyclohexylmethyl-2-oxoindol-3-yl)-1-methylquinolin-2(1H)-ketone ( R in the structural formula (I) is Cyclohexylmethyl, R2 is H, R3 is methyl, R4 is H)
在25mL反应瓶中分别加入N-环己基甲基吲哚(0.2mmol,42.7mg),N-甲基喹喔啉酮(0.22mmol,35.2mg),无水氯化铈(0.001mmol,0.25mg),3mL乙腈,在室温蓝光照射条件下反应1小时;随后在反应体系当中缓慢加入N-氟代双苯磺酰胺(0.3mmol,94.6mg),在50℃条件下继续反应3h,反应用TLC检测。待反应完成后,旋干乙腈,加入乙醇溶解混合物后,缓慢滴加水直到反应液逐渐浑浊,降温至0℃继续搅拌20min析料,过滤,用石油醚/乙酸乙酯(3/1)的混合溶液洗涤滤饼三次,真空干燥得到目标产物3-(3-氟-1-环己基甲基-2-氧代吲哚-3-基)-1-甲基喹啉-2(1H)-酮,产率为95%。N-cyclohexylmethylindole (0.2mmol, 42.7mg), N-methylquinoxalinone (0.22mmol, 35.2mg), anhydrous cerium chloride (0.001mmol, 0.25mg ), 3mL of acetonitrile, and reacted for 1 hour at room temperature under blue light irradiation; then slowly added N-fluorobisbenzenesulfonamide (0.3mmol, 94.6mg) into the reaction system, and continued the reaction at 50°C for 3h, and the reaction was performed by TLC detection. After the reaction is complete, spin dry the acetonitrile, add ethanol to dissolve the mixture, slowly add water dropwise until the reaction solution is gradually cloudy, cool down to 0°C and continue stirring for 20 minutes to separate the material, filter, and use a mixture of petroleum ether/ethyl acetate (3/1) The filter cake was washed three times with the solution, and vacuum-dried to obtain the target product 3-(3-fluoro-1-cyclohexylmethyl-2-oxoindol-3-yl)-1-methylquinolin-2(1H)-one , the yield was 95%.
3-(3-氟-1-环己基甲基-2-氧代吲哚-3-基)-1-甲基喹啉-2(1H)-酮的结构表征核磁共振数据如图1所示:1H NMR(400MHz,DMSO-d6)δ8.04(dd,J=8.1,1.5Hz,1H),7.76(ddd,J=8.6,7.3,1.6Hz,1H),7.64(d,J=8.5Hz,1H),7.54–7.45(m,2H),7.27–7.21(m,2H),7.02(t,J=7.5Hz,1H),3.61(dd,J=7.0,2.0Hz,2H),3.57(s,3H),1.87(dt,J=12.4,3.5Hz,2H),1.80–1.69(m,3H),1.66–1.60(m,1H),1.26–1.17(m,3H),1.08(tt,J=11.9,6.4Hz,2H);13C NMR(101MHz,DMSO-d6)δ152.12,146.32,133.70,132.56,132.24,132.13,130.41,125.04,124.70,124.32,123.07,115.69,110.48,46.43,36.41,30.69,29.40,26.39,25.81;19F NMR(471MHz,DMSO-d6)δ-159.67.The structural characterization of 3-(3-fluoro-1-cyclohexylmethyl-2-oxoindol-3-yl)-1-methylquinolin-2(1H)-one NMR data is shown in Figure 1 : 1 H NMR (400MHz, DMSO-d 6 ) δ8.04 (dd, J = 8.1, 1.5Hz, 1H), 7.76 (ddd, J = 8.6, 7.3, 1.6Hz, 1H), 7.64 (d, J = 8.5Hz, 1H), 7.54–7.45(m, 2H), 7.27–7.21(m, 2H), 7.02(t, J=7.5Hz, 1H), 3.61(dd, J=7.0, 2.0Hz, 2H), 3.57(s,3H),1.87(dt,J=12.4,3.5Hz,2H),1.80–1.69(m,3H),1.66–1.60(m,1H),1.26–1.17(m,3H),1.08( tt, J=11.9, 6.4Hz, 2H); 13 C NMR (101MHz, DMSO-d 6 ) δ152.12, 146.32, 133.70, 132.56, 132.24, 132.13, 130.41, 125.04, 124.70, 124.32, 123.07, 115.6 9,110.48,46.43 , 36.41, 30.69, 29.40, 26.39, 25.81; 19 F NMR (471MHz, DMSO-d 6 ) δ-159.67.
分析结果表明,获得的目标产物正确。The analysis results showed that the obtained target product was correct.
实施例2Example 2
以二氯乙烷代替乙腈,制备得到的目标产物的产率为90%。Using dichloroethane instead of acetonitrile, the yield of the target product was 90%.
实施例3Example 3
以N,N-二甲基甲酰胺(DMF)代替乙腈,制备得到的目标产物的产率为72%。Using N,N-dimethylformamide (DMF) instead of acetonitrile, the yield of the target product was 72%.
实施例4Example 4
5-溴-1-甲基-1H-吲哚的制备(结构式(II)中的R1为甲基,R2为吲哚5位取代的溴)Preparation of 5-bromo-1-methyl-1H-indole (R in structural formula (II) 1 is a methyl group, R 2 is bromine substituted at the 5-position of indole)
在50mL圆底烧瓶中分别加入5-溴-1H-吲哚(13.2mmol,2.6g),氢氧化钾(46.2mmol,2.60g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加碘甲烷(15.84mmol,2.2g)的DMF溶液,滴加完毕后在室温下继续反应3个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,干燥,旋干,以石油醚和乙酸乙酯(80:1)比例为洗脱液过柱纯化,晾干后得到5-溴-1-甲基-1H-吲哚。Add 5-bromo-1H-indole (13.2mmol, 2.6g), potassium hydroxide (46.2mmol, 2.60g), 15mL N,N-dimethylformamide (DMF) respectively in 50mL round bottom flask, in After stirring in an ice bath, a DMF solution of iodomethane (15.84 mmol, 2.2 g) was added dropwise to the round bottom flask. After the dropwise addition, the reaction was continued at room temperature for 3 hours, and the reaction was detected by TLC. After the reaction was completed, the reaction solution was washed with saturated ammonium chloride solution, extracted with ethyl acetate, and the organic phase was washed with brine, the organic phase was separated, dried, spin-dried, and extracted with petroleum ether and ethyl acetate (80:1 ) ratio is that the eluent is purified through the column, and 5-bromo-1-methyl-1H-indole is obtained after drying.
3-(5-溴-3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮的制备(结构式(I)中R1为甲基、R2为吲哚5位取代的溴、R3为甲基,R4为H)The preparation of 3-(5-bromo-3-fluoro-1-methyl-2-oxoindoline-3-yl)-1-methylquinolin-2(1H)-ketone (in structural formula (I) R 1 is methyl, R 2 is bromine substituted at the 5-position of indole, R 3 is methyl, R 4 is H)
在25mL反应瓶中分别加入5-溴-1-甲基-1H-吲哚(0.2mmol,42mg),N-甲基喹喔啉酮(0.22mmol,35.2mg),无水氯化铈(0.002mmol,0.25mg),3mL乙腈,在室温蓝光照射条件下反应3小时;随后在反应体系当中缓慢加入N-氟代双苯磺酰胺(0.3mmol,94.6mg),在50℃条件下继续反应3h,反应用TLC检测。待反应完成后,旋干乙腈,加入乙醇溶解混合物后,缓慢滴加水直到反应液逐渐浑浊,降温至0℃继续搅拌20min析料,过滤,用石油醚/乙酸乙酯(3/1)的混合溶液洗涤滤饼三次,真空干燥得到目标产物3-(5-溴-3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮,产率为92%。Add 5-bromo-1-methyl-1H-indole (0.2mmol, 42mg), N-methylquinoxalinone (0.22mmol, 35.2mg), anhydrous cerium chloride (0.002 mmol, 0.25 mg), 3 mL of acetonitrile, and react under blue light irradiation at room temperature for 3 hours; then slowly add N-fluorobisbenzenesulfonamide (0.3 mmol, 94.6 mg) into the reaction system, and continue the reaction at 50 ° C for 3 h , the reaction was detected by TLC. After the reaction is complete, spin dry the acetonitrile, add ethanol to dissolve the mixture, slowly add water dropwise until the reaction solution is gradually cloudy, cool down to 0°C and continue to stir for 20 minutes to separate the material, filter, and use a mixture of petroleum ether/ethyl acetate (3/1) The filter cake was washed three times with the solution, and vacuum-dried to obtain the target product 3-(5-bromo-3-fluoro-1-methyl-2-oxoindoline-3-yl)-1-methylquinoline-2(1H )-ketone, the yield is 92%.
3-(5-溴-3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮的结构表征核磁共振数据:1H NMR(400MHz,Chloroform-d)δ8.14(dd,J=8.0,1.5Hz,1H),7.69(ddd,J=8.6,7.2,1.5Hz,1H),7.57(dt,J=8.3,2.0Hz,1H),7.53–7.46(m,1H),7.43–7.36(m,2H),6.86(dd,J=8.3,1.2Hz,1H),3.64(d,J=1.6Hz,3H),3.37(s,3H);13C NMR(101MHz,Chloroform-d)δ169.64,152.36,151.51,145.18,145.13,134.82,134.79,133.37,132.56,131.85,131.16,127.95,125.95,124.51,115.43,115.39,113.91,110.53,90.34,29.09,26.79;19F NMR(376MHz,Chloroform-d)δ-163.51.Structural characterization of 3-(5-bromo-3-fluoro-1-methyl-2-oxoindolin-3-yl)-1-methylquinolin-2(1H)-one NMR data: 1 H NMR (400MHz, Chloroform-d) δ8.14 (dd, J = 8.0, 1.5Hz, 1H), 7.69 (ddd, J = 8.6, 7.2, 1.5Hz, 1H), 7.57 (dt, J = 8.3, 2.0 Hz,1H),7.53–7.46(m,1H),7.43–7.36(m,2H),6.86(dd,J=8.3,1.2Hz,1H),3.64(d,J=1.6Hz,3H),3.37 (s,3H); 13 C NMR(101MHz,Chloroform-d)δ169.64,152.36,151.51,145.18,145.13,134.82,134.79,133.37,132.56,131.85,131.16,127.95,125.95,124. 51,115.43,115.39,113.91, 110.53, 90.34, 29.09, 26.79; 19 F NMR (376MHz, Chloroform-d) δ-163.51.
分析结果表明,获得的目标产物正确。The analysis results showed that the obtained target product was correct.
实施例5Example 5
N-甲基吲哚的制备(结构式(II)中的R1为甲基,R2为H)The preparation of N-methylindole (R in structural formula (II) 1 is a methyl group, R 2 is H)
在50mL圆底烧瓶中分别加入吲哚(13.2mmol,1.55g),氢氧化钾(46.2mmol,2.60g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加碘甲烷(15.84mmol,2.25g)的DMF溶液,滴加完毕后在室温下继续反应3个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,干燥,旋干,以石油醚和乙酸乙酯(80:1)比例为洗脱液过柱纯化,晾干后得到N-甲基吲哚。Add respectively indole (13.2mmol, 1.55g) in 50mL round bottom flask, potassium hydroxide (46.2mmol, 2.60g), 15mL N,N-dimethylformamide (DMF), stir under ice bath, then A DMF solution of iodomethane (15.84 mmol, 2.25 g) was added dropwise to the round bottom flask, and after the dropwise addition was completed, the reaction was continued at room temperature for 3 hours, and the reaction was detected by TLC. After the reaction was completed, the reaction solution was washed with saturated ammonium chloride solution, extracted with ethyl acetate, and the organic phase was washed with brine, the organic phase was separated, dried, spin-dried, and extracted with petroleum ether and ethyl acetate (80:1 ) ratio is that the eluent is purified through the column, and N-methylindole is obtained after drying.
6-溴-1-甲基喹啉-2(1H)-酮的制备(结构式(III)中R3为甲基、R4为喹啉酮6位取代的溴)Preparation of 6-bromo-1-methylquinolin-2(1H)-one (R in structural formula (III) 3 is methyl, R 4 is bromine substituted at the 6-position of quinolinone)
在100mL圆底烧瓶中分别加入6-溴喹啉-2(1H)-酮(12mmol,2.7g),碳酸钾(24mmol,3.31g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加碘甲烷(14.4mmol,2g)的DMF溶液,滴加完毕后在室温下继续反应6个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,旋干得到粗品,粗品再用乙酸乙酯/石油醚(1:3)进行重结晶得到较纯的6-溴-1-甲基喹啉-2(1H)-酮。Add 6-bromoquinolin-2 (1H)-ketone (12mmol, 2.7g) respectively in 100mL round bottom flask, potassium carbonate (24mmol, 3.31g), 15mL N,N-dimethylformamide (DMF), After stirring in an ice bath, a DMF solution of iodomethane (14.4 mmol, 2 g) was added dropwise to the round bottom flask. After the dropwise addition, the reaction was continued at room temperature for 6 hours, and the reaction was detected by TLC. After the reaction was completed, the reaction solution was washed with saturated ammonium chloride solution, extracted with ethyl acetate, the organic phase was washed with brine, the organic phase was separated, and spin-dried to obtain the crude product, which was then washed with ethyl acetate/petroleum ether (1 :3) recrystallization is carried out to obtain relatively pure 6-bromo-1-methylquinolin-2 (1H)-one.
6-溴-3-(3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮的制备(结构式(I)中R1为甲基、R2为H、R3为甲基,R4为喹啉酮6位取代的溴)The preparation of 6-bromo-3-(3-fluoro-1-methyl-2-oxoindoline-3-yl)-1-methylquinolin-2(1H)-ketone (in structural formula (I) R 1 is methyl, R 2 is H, R 3 is methyl, R 4 is bromine substituted at the 6-position of quinolinone)
在25mL反应瓶中分别加入N-甲基吲哚(0.2mmol,26.2mg),6-溴-1-甲基喹啉-2(1H)-酮(0.22mmol,52.6mg),无水氯化铈(0.002mmol,0.25mg),3mL乙腈,在室温蓝光照射条件下反应3小时;随后在反应体系当中缓慢加入N-氟代双苯磺酰胺(0.3mmol,94.6mg),在50℃条件下继续反应3h,反应用TLC检测。待反应完成后,旋干乙腈,加入乙醇溶解混合物后,缓慢滴加水直到反应液逐渐浑浊,降温至0℃继续搅拌20min析料,过滤,用石油醚/乙酸乙酯(3/1)的混合溶液洗涤滤饼三次,真空干燥得到目标产物6-溴-3-(3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮,产率为93%。Add N-methylindole (0.2mmol, 26.2mg), 6-bromo-1-methylquinolin-2(1H)-one (0.22mmol, 52.6mg) into a 25mL reaction flask, anhydrous chlorination Cerium (0.002mmol, 0.25mg), 3mL of acetonitrile, reacted at room temperature under blue light irradiation for 3 hours; then slowly added N-fluorobisbenzenesulfonamide (0.3mmol, 94.6mg) into the reaction system, at 50°C The reaction was continued for 3h, and the reaction was detected by TLC. After the reaction is complete, spin dry the acetonitrile, add ethanol to dissolve the mixture, slowly add water dropwise until the reaction solution is gradually cloudy, cool down to 0°C and continue stirring for 20 minutes to separate the material, filter, and use a mixture of petroleum ether/ethyl acetate (3/1) The filter cake was washed three times with the solution, and vacuum-dried to obtain the target product 6-bromo-3-(3-fluoro-1-methyl-2-oxoindoline-3-yl)-1-methylquinoline-2(1H )-ketone, the yield is 93%.
6-溴-3-(3-氟-1-甲基-2-氧代吲哚啉-3-基)-1-甲基喹啉-2(1H)-酮的结构表征核磁共振数据:1H NMR(400MHz,Chloroform-d)δ8.30(s,1H),7.76(d,J=8.8Hz,1H),7.46(t,J=7.7Hz,1H),7.25(d,J=8.9Hz,2H),7.05(t,J=7.5Hz,1H),6.97(d,J=7.8Hz,1H),3.60(s,3H),3.38(s,3H);13C NMR(101MHz,Chloroform-d)δ153.78,152.05,134.32,133.40,133.26,132.51,132.28,132.25,124.79,123.90,123.72,123.07,123.04,116.97,115.29,109.13,92.75,29.20,26.70;19F NMR(376MHz,Chloroform-d)δ-163.49.Structural characterization of 6-bromo-3-(3-fluoro-1-methyl-2-oxoindolin-3-yl)-1-methylquinolin-2(1H)-one NMR data: 1 H NMR (400MHz, Chloroform-d) δ8.30(s, 1H), 7.76(d, J=8.8Hz, 1H), 7.46(t, J=7.7Hz, 1H), 7.25(d, J=8.9Hz , 2H), 7.05(t, J=7.5Hz, 1H), 6.97(d, J=7.8Hz, 1H), 3.60(s, 3H), 3.38(s, 3H); 13 C NMR (101MHz, Chloroform- d) δ153.78, 152.05, 134.32, 133.40, 133.26, 132.51, 132.28, 132.25, 124.79, 123.90, 123.72, 123.07, 123.04, 116.97, 115.29, 109.13, 92.75, 2 9.20, 26.70; 19 F NMR (376MHz, Chloroform-d) δ-163.49.
分析结果表明,获得的目标产物正确。The analysis results showed that the obtained target product was correct.
实施例6Example 6
N-炔丙基喹喔啉酮的制备(结构式(II)中R1为炔丙基、R2为H)The preparation of N-propargylquinoxalinone (in the structural formula (II) , R1 is propargyl, R2 is H)
在100mL圆底烧瓶中分别加入2-羟基喹喔啉酮(12mmol,1.75g),碳酸钾(24mmol,3.31g),15mL N,N-二甲基甲酰胺(DMF),于冰浴下搅拌,然后向圆底烧瓶中滴加3-溴丙炔(14.4mmol,1.71g)的DMF溶液,滴加完毕后在室温下继续反应6个小时,反应用TLC检测。待反应完成后,将反应溶液用饱和氯化铵溶液洗涤,乙酸乙酯萃取,有机相再用食盐水洗涤,分出有机相,干燥,旋干的到粗品,粗品再用乙酸乙酯/石油醚(1:4)进行重结晶得到较纯的N-炔丙基喹喔啉酮。Add respectively 2-hydroxyquinoxalinone (12mmol, 1.75g), potassium carbonate (24mmol, 3.31g), 15mL N,N-dimethylformamide (DMF) in 100mL round bottom flask, stir under ice bath , Then in the round bottom flask, dropwise add the DMF solution of 3-bromopropyne (14.4mmol, 1.71g), continue to react at room temperature for 6 hours after the dropwise addition, and the reaction is detected by TLC. After the reaction is completed, the reaction solution is washed with saturated ammonium chloride solution, extracted with ethyl acetate, the organic phase is washed with brine, the organic phase is separated, dried, and spin-dried to obtain the crude product, which is then washed with ethyl acetate/petroleum Ether (1:4) was recrystallized to obtain relatively pure N-propargylquinoxalinone.
3-(3-氟-1-甲基-2-氧代吲哚-3-基)-1-炔丙基喹恶啉-2(1H)-酮的制备(结构式(I)中R1为炔丙基、R2为H、R3为甲基,R4为H)The preparation of 3-(3-fluoro-1-methyl-2-oxoindol-3-yl)-1-propargylquinoxaline-2(1H)-ketone ( R in the structural formula (I) is propargyl, R2 is H, R3 is methyl, R4 is H)
在25mL反应管中分别加入N-甲基吲哚(0.2mmol,26.2mg),N-炔丙基喹喔啉酮(0.22mmol,40.5mg),无水氯化铈(0.001mmol,0.25mg),3mL乙腈,在室温蓝光照射条件下反应1小时;随后在反应体系当中缓慢加入N-氟代双苯磺酰胺(0.3mmol,94.6mg),在50℃条件下继续反应3h,反应用TLC检测。待反应完成后,旋干乙腈,加入乙醇溶解混合物后,缓慢滴加水直到反应液逐渐浑浊,降温至0℃继续搅拌20min析料,过滤,用石油醚/乙酸乙酯(3/1)的混合溶液洗涤滤饼三次,真空干燥得到目标产物3-(3-氟-1-甲基-2-氧代吲哚-3-基)-1-炔丙基喹恶啉-2(1H)-酮,产率为92%。Add N-methylindole (0.2mmol, 26.2mg), N-propargylquinoxalinone (0.22mmol, 40.5mg) and anhydrous cerium chloride (0.001mmol, 0.25mg) respectively in a 25mL reaction tube , 3mL acetonitrile, reacted under blue light irradiation at room temperature for 1 hour; then slowly added N-fluorobisbenzenesulfonamide (0.3mmol, 94.6mg) into the reaction system, and continued the reaction at 50°C for 3h, and the reaction was detected by TLC . After the reaction is complete, spin dry the acetonitrile, add ethanol to dissolve the mixture, slowly add water dropwise until the reaction solution is gradually cloudy, cool down to 0°C and continue stirring for 20 minutes to separate the material, filter, and use a mixture of petroleum ether/ethyl acetate (3/1) The filter cake was washed three times with the solution, and vacuum-dried to obtain the target product 3-(3-fluoro-1-methyl-2-oxoindol-3-yl)-1-propargylquinoxaline-2(1H)-one , the yield was 92%.
3-(3-氟-1-甲基-2-氧代吲哚-3-基)-1-炔丙基喹恶啉-2(1H)-酮的结构表征核磁共振数据如下所示:1H NMR(400MHz,Chloroform-d)δ8.16(d,J=8.0Hz,1H),7.64(t,J=7.8Hz,1H),7.49–7.43(m,2H),7.38–7.31(m,2H),7.05(t,J=7.5Hz,1H),6.97(d,J=7.8Hz,1H),5.90–5.79(m,1H),4.85–4.79(m,2H),3.39(s,3H).The structural characterization of 3-(3-fluoro-1-methyl-2-oxoindol-3-yl)-1-propargylquinoxaline-2(1H)-one The NMR data are as follows: 1 H NMR (400MHz, Chloroform-d) δ8.16(d, J=8.0Hz, 1H), 7.64(t, J=7.8Hz, 1H), 7.49–7.43(m, 2H), 7.38–7.31(m, 2H), 7.05(t, J=7.5Hz, 1H), 6.97(d, J=7.8Hz, 1H), 5.90–5.79(m, 1H), 4.85–4.79(m, 2H), 3.39(s, 3H ).
分析结果表明,获得的目标产物正确。The analysis results showed that the obtained target product was correct.
应当指出的是,对于本领域的普通技术人员来说,在不脱离本申请构思的前提下,还可以做出若干变形和改进,这些都属于本申请的保护范围。It should be noted that those skilled in the art can make several modifications and improvements without departing from the concept of the present application, and these all belong to the protection scope of the present application.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211335843.8A CN115960085A (en) | 2022-10-28 | 2022-10-28 | Preparation method of fluoro-oxindole heterocyclic compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211335843.8A CN115960085A (en) | 2022-10-28 | 2022-10-28 | Preparation method of fluoro-oxindole heterocyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115960085A true CN115960085A (en) | 2023-04-14 |
Family
ID=87362495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211335843.8A Withdrawn CN115960085A (en) | 2022-10-28 | 2022-10-28 | Preparation method of fluoro-oxindole heterocyclic compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115960085A (en) |
-
2022
- 2022-10-28 CN CN202211335843.8A patent/CN115960085A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101440257B1 (en) | Process for the manufacture of intermediates for preparing pharmaceutically active compounds | |
CN111471047B (en) | Method for the selective synthesis of pyrazolo[1,2-a]pyrazolones or 2-acylindole compounds | |
CN101679353A (en) | A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 | |
CN107141246B (en) | A kind of preparation method of Isatine derivatives | |
CN115010644B (en) | A kind of preparation method of 2,3-disubstituted indoline compounds | |
CN106117216B (en) | A kind of method of atmospheric synthesis 6H- iso-indoles [2,1-a] indoles -6- ketone compounds | |
CN113444076B (en) | Application of biomass loaded copper catalytic three-component reaction in preparation of fluorine-containing medicament | |
CN113185536B (en) | A kind of synthetic method of pyrazolidinone-benzo-1,3-oxazepine compounds | |
JP6904519B2 (en) | Manufacturing methods and intermediates for synthesizing intermediates for the antitumor drug niraparib | |
RU2709493C1 (en) | Method of producing roxadustat | |
CN115960085A (en) | Preparation method of fluoro-oxindole heterocyclic compound | |
CN109535086B (en) | Synthetic method of quinoxaline-2 (1H) -ketone C-3 carboxylate compound | |
CN113912609B (en) | Preparation method of natural alkaloid tryptanthrin and derivatives thereof | |
CN107513056B (en) | A kind of synthetic method of quinoline compound containing tetrahydrofuran group | |
CN113388852B (en) | Method for synthesizing polysubstituted pyrido [1,2-e ] purine compound by electrochemical dehydrogenation coupling | |
CN110776510B (en) | Preparation method of 1- (2-quinolyl) -beta-carboline natural product and derivative | |
CN107216326A (en) | (1,2,3 triazoles)The synthetic method of the carboxylic acid ethyl ester compound of [1,5 f] phenanthridines 10 | |
CN107382897A (en) | A kind of intermediate of betrixaban and its preparation method and application | |
CN114874190B (en) | Method for preparing fluorine-containing oxindole derivative by one-pot catalysis | |
CN115745967A (en) | Application of photo-promoted copper catalytic tandem reaction in preparation of fluorine-containing medicament | |
CN107721917B (en) | A kind of green synthesis method of polysubstituted nicotinic acid ester compounds | |
CN114524805B (en) | Application of solid acid catalyzed multicomponent reaction in the preparation of fluorine-containing drugs | |
CN113121435B (en) | Synthetic method of 2, 4-dichloroquinoline compound | |
CN112209867B (en) | A kind of synthetic method of 2-alkynyl substituted indole compounds | |
CN111116552B (en) | Quinazolinone compound and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230414 |
|
WW01 | Invention patent application withdrawn after publication |